, Tracking Stock Market Picks
Enter Symbol:
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Sell SNN
down 40.97 %

Smith & Nephew Snats, Inc. (SNN) rated Sell by Societe Generale

Posted on: Wednesday,  Oct 10, 2012  8:25 AM ET by Societe Generale

Societe Generale rated Sell Smith & Nephew Snats, Inc. (NYSE: SNN) on 10/10/2012, when the stock price was $20.94.
Since then, Smith & Nephew Snats, Inc. has gained 69.42% as of 12/07/2015's recent price of $35.47.
If you would have followed this Societe Generale's recommendation on SNN, you would have lost 40.97% of your investment in 1153 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Societe Generale
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2012 8:25 AM Sell
as of 12/31/2012
1 Week down  -0.39 %
1 Month down  -4.98 %
3 Months down  -5.84 %
1 YTD down  -5.84 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy